Researchers assessed accommodative changes after foldable iris-fixated phakic IOL implantation for myopic astigmatism
Articles
AI models predicting retinal function from OCT could transform geographic atrophy assessment in clinical care and trials
This is a promotional supplement commissioned by Roche Products Limited.
Two cases highlight the diagnostic challenges of Demodex blepharitis and underscore the unmet need for approved targeted therapies in the United Kingdom.
Utilize oral agents, diet and glucose monitoring systems when acting to preserve vision
A scoping review finds limited evidence on transition programmes for adolescents moving from paediatric to adult ophthalmology care
A sutureless amniotic membrane matrix achieved faster healing and lower costs than standard PED care in a two-centre NHS audit.
A retrospective study of 114 oculoplastic surgery patients found trehalose added to sodium hyaluronate improved tear break-up time, corneal staining, and meibomian gland loss compared with sodium hyaluronate alone, particularly after eyelid reconstruction.
The CE-marked lens is being placed by selected surgeons across 6 European countries under a company-described early-access program
New pathways are reshaping the management of retinal disease
Immediate flushing of the eye can significantly reduce long-term damage after chemical exposure
After accounting for key factors like eye length, researchers found no meaningful differences in corneal biomechanics between primary open-angle and primary angle-closure glaucoma.
The update introduces a 250 kHz scan speed for OCT Angiography combined with enhanced TruTrack Active Eye Tracking, as well as new multimodal imaging capabilities, including the Green Autofluorescence Module
Alkeus Pharmaceuticals has dosed the first participant in the phase 3 NORTHSTAR trial of oral gildeuretinol for Stargardt disease, a condition with no approved treatments.
Examining the physiologic limits can help identify when its usage may be ineffective
Understanding the different expectations between patients with these conditions is key to choosing the appropriate refractive surgery.
Samsung Bioepis launched Opuviz, an aflibercept biosimilar, in Europe for wet AMD, DME, retinal vein occlusion, and myopic CNV.
The 17th European Glaucoma Society (EGS) Congress—being held in Brussels, Belgium, from 30 May to 2 June 2026—brings together glaucoma specialists across plenary sessions, hands-on surgical dry labs, national society symposia and cross-specialty debates.
A retrospective study from a UK tertiary centre reports satisfactory visual and topographic outcomes in patients monitored and treated by optometrists and nurse practitioners.
The incision-free, image-guided femtosecond laser system targets the trabecular meshwork to reduce IOP without entering the eye. Prof. Gus Gazzard discusses the technology, the patient experience and the potential for earlier interventional glaucoma treatment
Swiss regulator backs tinlarebant for Stargardt as DRAGON phase 3 shows slower retinal atrophy, bringing first treatment closer to patients.
The novel dual-port cutter, designed for use with the Stellaris Elite platform, offers increased flow rate and reduced cutter vibration.
Emerging evidence repositions role of selective laser trabeculoplasty
Ultra-widefield imaging reveals early retinal risk in paediatric patients.
Professor Alió reflects on a new comprehensive volume dedicated to aging in ophthalmology
Temporal optical coherence tomography modelling may improve longitudinal disease tracking.
The dual-function phaco-vitrectomy platform is cleared for European commercialization, with launch targeted for Q3 2026.
Understanding thyroid eye disease and its often-missed diagnosis.
A closer look at the science powering next-generation retinal treatments.
Advertisement
Advertisement